戻る
ABPRO Holdings Inc (ABP)価格
ABP 株価推移チャート
ABP 収入
ABPRO Holdings Inc
$3.5
-1.68%
$-0.06
終値： Jan 16, 16:00:00 GMT-5
$3.49
-0.28%
$0
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$3.56
始値
$3.65
当日レンジ
$3.4 - $3.84
52週レンジ
$3.4 - $42.6
取引高
5.3K
平均取引高
109.9K
1株当たり利益(TTM)
-9.39
配当利回り
--
時価総額
$9.4M
ABPとは何ですか？
ABPRO Holdings Inc is a US-based company operating in Biotechnology industry. The company is headquartered in New York City, New York and currently employs 6 full-time employees. The company went IPO on 2022-01-14. Abpro Holdings, Inc. is a biotechnology company. The firm is advancing a pipeline of next generation antibody therapies for human epidermal growth factor receptor 2 (HER2)+cancers, non-HER2+ gastric and liver cancer, and wet age-related macular degeneration and diabetic macular edema. These antibodies are developed using the Company’s proprietary DiversImmune platform. Its two lead product candidates, ABP-102 and ABP-201, feature its next generation tetravalent antibody format (TetraBi antibody format), which binds to two different targets with two distinct binding sites per target. ABP-102 is designed to redirect a patient’s immune system to fight cancer by engaging T cells through co-targeting HER2, and CD3, T-cell co-receptor. ABP-201 is designed to block blood vessel formation and normalize damaged vessels through co-targeting VEGF and ANG-2. The company plans to develop ABP-201 to treat vascular disease of the eye, focusing on wet age-related macular degeneration (Wet AMD).